Mission Statement
Center for Pathophysiology, Infectiology and Immunology
A number of research initiatives and scientific achievements of the » Medical University of Vienna originate from the research area immunology/allergology/infectiology. To strengthen this successful research field further, the University defined in its development plan 2009 immunology/allergology/infectiology as one of its 4 main research clusters. As organizational measure, the University founded the Center for Pathophysiology, Infectiology and Immunology (CePII) that concentrates most of the research laboratories of the preclinical school working in pathophysiology, infectiology and immunology. Within the Center the research laboratories are substructured in 4 institutes to use more efficiently the resources and to better plan common activities:
» Institute for Hygiene and Applied Immunology [HAI]
» Institute of Immunology [IFI]
» Institute for Pathophysiology and Allergy Research [IPA]
» Institute for Specific Prophylaxis and Tropical Medicine [ISPTM]
» more information about the CePII and research area immunology/allergology/infectiology
Events
Friday, January 24, 2020, 02.30 pm, Hygiene Institute, Lecture Hall 1, Kinderspitalgasse 15, Vienna IX
News
Die Sozialwissenschaftlerin Katharina T. Paul und die Immunologin Ursula Wiedermann-Schmidt diskutieren am 9. Juni 2020 Wirkung und mögliche Nebenwirkungen einer Impfpflicht. Seien Sie via Stream dabei!
Assoc. Prof. Dr. Isabella Ellinger (Institute of Pathophysiology and Allergy Research, CePII, MedUni Vienna) in collaboration with Assoc. Prof. Dr. Georg Dorffner (Section for Artificial Intelligence and Decision Support, MedUni Vienna) and Dr. Rupert Ecker (TissueGnostics, GmbH, Austria ) has started a 2-year Bridge – Young Scientists project entitled “Deep learning for improved nuclei segmentation and knowledge transfer methods in microscopic images”. From the total project costs (€ 300.000), € 240.000 are funded by the Austrian Research Promotion Agency (FFG).
Das Robert Koch-Institut (RKI) ist ein Bundesinstitut im Geschäftsbereich des Bundesministeriums für Gesundheit in Deutschland. Das RKI ist die zentrale Einrichtung der deutschen Bundesregierung auf dem Gebiet der Krankheitsüberwachung und -prävention und damit auch die zentrale Einrichtung des Bundes auf dem Gebiet der anwendungs- und maßnahmenorientierten biomedizinischen Forschung. Die Kernaufgaben des RKI sind die Erkennung, Verhütung und Bekämpfung von Krankheiten, insbesondere der Infektionskrankheiten.
Dr. Martin Schepelmann (Institute of Pathophysiology and Allergy Research, research group of Assoc. Prof. Dr. Enikö Kallay) received a grant of € 418,000, co-funded from the Herzfelder Family Foundation and the FWF (Austrian Science Fund), for his project “Effect of ageing on a chemically induced colon cancer model”.
